In an underlying patent infringement action concerning a long-acting injectable drug product for schizophrenia, the Court ruled on pre-trial evidentiary objections.
The Court excluded several statements in expert reports as inadmissible hearsay, but admitted others.
The Court also dismissed objections to expert qualifications, holding that Dr. Agid was qualified to opine on prescribing practices and Dr. Rabinow was qualified to give expert evidence on pH, particle size distribution, viscosity, and isotonicity.
